September 24, 2016 6:57 PM ET

Pharmaceuticals

Company Overview of Parnell Pharmaceuticals Holdings Ltd.

Executive Profile

Ellen B. Richstone

Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee, Parnell Pharmaceuticals Holdings Ltd.
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 11 different industries.

See Board Relationships
64--

Background

Ms. Ellen B. Richstone served as an Executive Vice President of Luminus Devices, Inc. Ms. Richstone serves as a Chief Financial Officer for public and private companies ranging in size from midcap to $3 billion in revenue. She has extensive experience both as a Board Director and as an Operating Executive. She was a Fortune 500 Chief Financial Officer. She served on companies ranging from early stage start-ups to S&P 500 companies. She served as the Chief Financial Officer ...

Corporate Headquarters

Century Estate
Alexandria, New South Wales 2015

Australia

Phone: --
Fax: --

Board Members Memberships

Director
Non-Executive Chairman
2004-Present
Director, Member of Compensation & Stock Option Committee and Member of Audit Committee
2012-Present
Director
2014-Present
Director, Chairman of Audit Committee and Member of Governance & Nominating Committee
2014-Present
Independent Director, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
2014-Present
Director and Chairman of Audit Committee
2015-Present
Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee

Education

BA
Scripps College
Master's Degree
Fletcher School of Law and Diplomacy, Tufts University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian D. Page Chief Executive Officer, Managing Director and Executive Director
Dechra Pharmaceuticals plc
$757.0K
Jack Clifford Bendheim Chairman, Chief Executive Officer, President and Member of Compensation Committee
Phibro Animal Health Corporation
$3.1M
Matthieu Frechin Chief Executive Officer, Director and Member of Strategy Committee
Vétoquinol SA
$402.0K
Steven St. Peter M.D.Co-Founder, Chief Executive Officer, President and Director
Aratana Therapeutics, Inc.
$467.5K
Lisa A. Conte Chief Executive Officer, President and Director
Jaguar Animal Health, Inc.
$466.5K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Parnell Pharmaceuticals Holdings Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.